In addition, HMGCR, a rate-limiting enzyme in endogenous cholesterol synthesis, has increased expression in NAFLD and NASH, and the degree of increase was related to the level of free cholesterol and the severity of liver disease-related (Min et al., 2012). Here, HMGCR is linked to metabolic dysfunction-associated steatotic liver disease.